United States: Lykos MDMA Submission Series A - Manatt, Phelps & Phillips LLP

On December 11, 2023, following positive results from two published Phase 3 studies, MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA)...